A decision-tree model to estimate the impact on cost-effectiveness of a venous thromboembolism prophylaxis guideline

Quality and Safety in Health Care

Volumn 18, Issue 4, 2009, Pages 309-313

  Ferrando, A ^a   Pagano, E ^a   Scaglione, L ^a   Petrinco, M ^a   Gregori, D ^a   Ciccone, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMBOLISM PREVENTION; HIGH RISK POPULATION; LUNG EMBOLISM; PRACTICE GUIDELINE; STATISTICAL MODEL; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; PRACTICE GUIDELINES AS TOPIC; STOCKINGS, COMPRESSION; VENOUS THROMBOEMBOLISM;

EID: 69449093201     PISSN: 14753898     EISSN: 14753901     Source Type: Journal    
DOI: 10.1136/qshc.2007.023135     Document Type: Article

References (22)

1. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Tecnol Assessment 2004;8:1-72. (Pubitemid 38279464)
2. Dismuke SE, Wagner EH. Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients. JAMA 1986;255:2039-2042
3. Goldhaber SZ, Visani L, RosaM. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389
4. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-938
5. Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery. N Engl J Med 1988;318:1162-1173 (Pubitemid 18117696)
6. Oster G, Truden RL, Colditz GA. Cost-effective analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery. JAMA 1987;257:203-205 (Pubitemid 17207832)
7. Second Thromboembolic Risk Factors (THRiFT II) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Phlebology 1998;13:87-97. (Pubitemid 29141315)
8. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):338-400S.
9. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism. An evaluation of the use of thromboprophylaxis guidelines. Chest 2001;120:1964-1971
10. Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002;87:746-750 (Pubitemid 34787146)
11. Ahmad HA, Geissler A, MacLellan DG. Deep vein thrombosis prophylaxis: are guidelines being followed? ANZ J Surg 2002;72:331-334
12. National Institute of Clinical Studies. Interventions to increase the uptake of venous thromboembolism prophylaxis in hospitals. Prepared by Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S). Melbourne: National Institute of Clinical Studies, 2003.
13. Tapson VF, Hyers TM, Waldo AL, et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med 2005;165:1458-1464
14. Burns SP, Nelson AL, Bosshart HT, et al. Implementation of clinical practice guidelines for prevention of thromboembolism in spinal cord injury. J Spinal CordMed 2005;28:33-42. (Pubitemid 43108146)
15. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-394
16. Scaglione L, Piobbici M, Pagano E, et al. Implementing a venous thromboembolism prophylaxis guideline in a large Italian teaching hospital: lights and shadows. Haematologica 2005;90:678-684 (Pubitemid 40780887)
17. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006.
18. Anon. Hospital guidelines for venous thromboembolism prophylaxis (in Italian). http://www.cpo.it/lineeguida/lgprofilassitvp.pdf (accessed 13 Jun 2008).
19. Muntz J, Scott DA, Lloyd A, et al. Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care 2004;20:405-414 (Pubitemid 39491486)
20. Davidson BL, Sullivan SD, Kahn SR, et al. The economics of venous thromboembolism prophylaxis: a primer for clinicians. Chest 2003;124(6 Suppl):393S-6S.
21. TreeAge Software. TreeAge Pro 2005 Suite Release 0.8. http://www.treeage.com/ (accessed 4 Jun 2009).
22. Schunemann HJ, Cook D, Grimshaw J, et al. Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):688-96S. (Pubitemid 39297953)